Point72 Europe (London) LLP Axsome Therapeutics, Inc. Transaction History
Point72 Europe (London) LLP
- $1.48 Billion
- Q3 2024
A detailed history of Point72 Europe (London) LLP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Point72 Europe (London) LLP holds 34,570 shares of AXSM stock, worth $3.68 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
34,570
Previous 30,741
12.46%
Holding current value
$3.68 Million
Previous $2.47 Million
25.55%
% of portfolio
0.21%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
327Shares Held
38MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$446 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$425 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$351 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$251 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$111 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.56B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...